Industry News, News

Ozempic, Mounjaro Lawsuits Consolidated in Federal Multidistrict Litigation

February 6, 2024
Medical law: books, gavel and stethoscope

A federal panel has consolidated at least 55 lawsuits against pharmaceutical companies Novo Nordisk and Eli Lilly into a multidistrict litigation in the Eastern District of Pennsylvania.

The lawsuits claim that these companies did not adequately warn people about the severe side effects associated with a class of prescription drugs including Ozempic and Mounjaro.

Plaintiffs’ lawyers anticipate filing up to 10,000 lawsuits related to Ozempic and similar drugs as part of the MDL.

Read more at Drugwatch.com >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available
    • Terri Ross Consulting Appoints Cameron Hemphill as Chief Operating Officer and Strategic Advisor